22nd May 2014Dr.Yot gave a Skype  interviewed to Richard Smith,Professor of Health System Economics & Dean of Faculty of Public Health & Policy, London School of Hygiene & Tropical Medicine for making the Health Economics and Health Technology Assessment (HTA) VideoHere’re some behind th

Epidemiological modelling is an important tool to help public health planners understand potential disease outcomes in the population. The recent visibility of models and their perceived influence in the decision-making processes surrounding the response to the COVID-19 pandemic has led to a great d

The Health Technology Assessment (HTA), which is a crucial tool for setting health intervention priorities, has been rapidly developing in Asia-Pacific, but is still not fully employed by many countries in policy decision making. Although HTA institutions and networks have been operating successfully in OECD countries and a few of the middle-income

In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht f

President Obama’s health care law is putting new strains on some of the nation’s most hard-pressed hospitals, by cutting aid they use to pay for emergency care for illegal immigrants, which they have long been required to provide.The federal government has been spending $20 billion annually to reimb

Background Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include li

Background: Telemedicine has transformed health care delivery, offering improved access, efficiency, and potentially cost-effectiveness. However, wide-scale implementation is challenged due to multiple factors. Among these, reimbursements were reported to influence the scalability and sustainabilit

ตลอดปี 2024 มูลนิธิเพื่อการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ หรือ HITAP Foundation เราได้สร้างสรรค์และผลิตผลงานตามพันธสัญญาที่เราตั้งไว้ เพื่อพัฒนาระบบการแพทย์สาธารณสุขไว้หลากหลายรูปแบบ ไม่ว่าจะเป็นการจัดงานประชุมและเวิร์คชอป เพื่อพัฒนาบุคลากรด้านการแพทย์สาธารณสุขทั้งในและต่างประเทศการผลิต Policy

Benjarin Santatiwongchai1, Varit Chantarastapornchit1*, Thomas Wilkinson2, Kittiphong Thiboonboon1, Waranya Rattanavipapong1, Damian G Walker3, Kalipso Chalkidou2, Yot Teerawattananon1 1 Health Intervention and Technology Assessment Program, Nonthaburi, Thailand, 2 NICE International,National Insti

Abstract BACKGROUND: Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) th